A tale of two different European equity markets A tale of two different European equity markets A tale of two different European equity markets

A tale of two different European equity markets

Equities 5 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  European equities are down 12% this year whereas US equities are in positive territory and emerging market equities are unchanged. But underneath the bad overall performance a tale of two different European equity markets is hiding showing that a passive approach to European equities that on all measures are extremely cheap is wrong. Investors have to be selective and in our view get exposure to the stable growth companies with high earnings predictability. Those companies will benefit more than others from the low interest rate environment.

In today’s Saxo Market Call podcast, we talked about how emerging market equities had almost fully recovered from the COVID-19 selloff whereas European equities had only recovered half of the drawdown. Asia and especially China is a big component in the emerging market index and the region seems to have managed the COVID-19 outbreak much better with their economic activity also bouncing back faster. As Europe’s rebound was under way a new resurgence in COVID-19 cases seems to be breaking the rebound playbook putting even more pressure on ECB on their Thursday press conference. You can read our ECB preview here.

Source: Bloomberg

Stock picking is crucial as there is no one Europe

Back in May we wrote a research note Have US equities finally peaked relative to European equities? Highlighting the grotesque difference in performance between US and European equities since 2007. Most of the outperformance is related to the facts that US companies are dominating the digital economy in the developed world and that European equity markets were still heavily overweight financials which have suffered in the post Great Financial Crisis period.

Whereas emerging market equities are almost unchanged for the year European equities are still down 12%. But Europe’s performance comes in different shades. As the table below indicates there are basically two groups this year in terms of performance. The best performing group consists of the markets: Denmark, Finland, Sweden, Netherlands, Switzerland, Germany, Portugal and Ireland which are up 1% on an equal-weight basis whereas the other group is down 20% with Austria being hit the hardest down 32% year-to-date.

MarketLargest sector12m Fwd P/EReturn YTD (%)Return 5yr (%)
DenmarkHealth care16.615.646.5
NetherlandsInformation technology15.6-1.056.1
SwitzerlandHealth care15.5-1.535.7
GermanyConsumer discretionary10.6-2.321.4
United KingdomConsumer staples9.3-20.514.7
BelgiumConsumer staples13.7-23.3-17.9

Source: Bloomberg and Saxo Group

This divergence in performance is also evident in the 5-year total return numbers so this is long-term trend that has persisted indicating the tale of two European equity markets. In terms of 12-month forward P/ E ratio the best performing group has an average ratio of 13.4x which is still low given the low interest rate environment and given valuation of US equities. The worst performing group has a forward P/E ratio of 9.6 indicating very low sentiment for these markets.

Our view is that valuations are very attractive in Europe relative to many other markets but that investors should be very selective and not buy passively into European equities. As we wrote recently earnings predictability drives valuation premium, so we recommend investors to look for stable growth companies in Europe and avoid the cheap cyclicals and especially financials.


The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.